The following table shows the list of Horizon 2020 projects developed by "OWKIN FRANCE". Projects are ordered by starting date.
Click on table headers to rearrange data.
# | acronym | programme | role | EC contrib. | start | views |
---|---|---|---|---|---|---|
1 | ImmunAID | H2020-EU.3.1.1. | participant | 383˙750.00 | 2018-05-01 | 8437 |
2 | IMMUcan | H2020-EU.3.1.7. | participant | 0.00 | 2019-03-01 | 342 |
3 | MELLODDY | H2020-EU.3.1.7. | coordinator | 2˙773˙635.00 | 2019-06-01 | 407 |
totale | 3˙157˙385.00 |
This organization collaborated with partners in 17 countries.
Within the project ImmunAID this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | CH | FMFandAID | FMF & AID GLOBAL ASSOCIATION (OTH) |
participant | FR | MANDA | MANDANOVA (PRC) |
participant | FR | ECRIN-ERIC | ECRIN EUROPEAN CLINICAL RESEARCH INFRASTRUCTURE NETWORK (REC) |
participant | FR | AMBIOTIS | AMBIOTIS (PRC) |
participant | ES | HSJD | HOSPITAL SANT JOAN DE DÉU (REC) |
participant | IT | OPBG | OSPEDALE PEDIATRICO BAMBINO GESU (OTH) |
participant | BE | CENTRE HOSPITALIER UNIVERSITAIRE DE LIEGE | CENTRE HOSPITALIER UNIVERSITAIRE DE LIEGE (REC) |
participant | EL | BRFAA | IDRYMA IATROVIOLOGIKON EREUNON AKADEMIAS ATHINON (REC) |
participant | FR | APHP | ASSISTANCE PUBLIQUE HOPITAUX DE PARIS (REC) |
participant | BE | VIB | VIB (REC) |
participant | EL | UOI | PANEPISTIMIO IOANNINON (HES) |
participant | DE | WWU | WESTFAELISCHE WILHELMS-UNIVERSITAET MUENSTER (HES) |
participant | SI | UKCL | UNIVERZITETNI KLINICNI CENTER LJUBLJANA (HES) |
participant | FR | INSTITUT CURIE | INSTITUT CURIE (REC) |
participant | TR | HUGEN | HACETTEPE UNIVERSITESI (HES) |
participant | CH | UNIGE | UNIVERSITE DE GENEVE (HES) |
participant | UK | UNIVLEEDS | UNIVERSITY OF LEEDS (HES) |
participant | UK | UCL | UNIVERSITY COLLEGE LONDON (HES) |
participant | BE | ULIEGE | UNIVERSITE DE LIEGE (HES) |
participant | NL | ERASMUS MC | ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM (HES) |
participant | DK | UCPH | KOBENHAVNS UNIVERSITET (HES) |
participant | BE | KU Leuven | KATHOLIEKE UNIVERSITEIT LEUVEN (HES) |
participant | FR | CEA | COMMISSARIAT A L ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (REC) |
coordinator | FR | INSERM | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (REC) |
Within the project IMMUcan this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | FR | LCC | LIGUE NATIONALE CONTRE LE CANCER (REC) |
participant | DE | Bayer AG | BAYER AKTIENGESELLSCHAFT (PRC) |
participant | US | AbbVie | ABBVIE INC (PRC) |
participant | BE | IJB | INSTITUT JULES BORDET (HES) |
participant | UK | Eli Lilly | Eli Lilly and Company Limited (PRC) |
participant | FR | IRIS | INSTITUT DE RECHERCHES INTERNATIONALES SERVIER (PRC) |
participant | BE | DDUV | DE DUVE INSTITUTE (REC) |
participant | FR | PIERRE FABRE | INSTITUT DE RECHERCHE PIERRE FABRESAS (PRC) |
participant | FR | CLB | CENTRE DE LUTTE CONTRE LE CANCER LEON BERARD (REC) |
participant | FR | SARD | SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT (PRC) |
participant | LU | LIH | LUXEMBOURG INSTITUTE OF HEALTH (REC) |
participant | BE | JANSSEN | JANSSEN PHARMACEUTICA NV (PRC) |
participant | LU | EPF | FORUM EUROPEEN DES PATIENTS (FPE) (OTH) |
coordinator | BE | EORTC | EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER AISBL (REC) |
participant | ES | CRG | FUNDACIO CENTRE DE REGULACIO GENOMICA (REC) |
participant | CH | CHUV | CENTRE HOSPITALIER UNIVERSITAIRE VAUDOIS (PUB) |
participant | CH | SIB | SIB INSTITUT SUISSE DE BIOINFORMATIQUE (REC) |
participant | FR | IC | INSTITUT CURIE (REC) |
participant | UK | UoB | THE UNIVERSITY OF BIRMINGHAM (HES) |
participant | UK | GSK | GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD. (PRC) |
participant | DE | Merck | MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN (PRC) |
participant | CH | UZH | UNIVERSITAT ZURICH (HES) |
participant | IL | WEIZMANN | WEIZMANN INSTITUTE OF SCIENCE (HES) |
participant | UK | KCL | KING'S COLLEGE LONDON (HES) |
participant | BE | KUL | KATHOLIEKE UNIVERSITEIT LEUVEN (HES) |
participant | DE | CHA | CHARITE - UNIVERSITAETSMEDIZIN BERLIN (HES) |
participant | FR | INSERM | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (REC) |
Within the project MELLODDY this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | DE | AmgenResMunich | AMGEN RESEARCH (MUNICH) GMBH (PRC) |
participant | FR | Iktos | IKTOS (PRC) |
participant | DE | Loodse GmbH | LOODSE GMBH (PRC) |
participant | FR | SubstraF | SUBSTRA (OTH) |
participant | DE | Bayer AG | BAYER AKTIENGESELLSCHAFT (PRC) |
participant | CH | NVIDIA SWISS AG | NVIDIA SWITZERLAND AG (PRC) |
participant | NL | Astellas | ASTELLAS PHARMA EUROPE BV (PRC) |
participant | DE | BI | BOEHRINGER INGELHEIM INTERNATIONALGMBH (PRC) |
participant | BE | JANSSEN | JANSSEN PHARMACEUTICA NV (PRC) |
participant | CH | NOVARTIS | NOVARTIS PHARMA AG (PRC) |
participant | HU | BME | BUDAPESTI MUSZAKI ES GAZDASAGTUDOMANYI EGYETEM (HES) |
participant | UK | GSK | GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD. (PRC) |
participant | SE | MEDIMMUNE | ASTRAZENECA AB (PRC) |
participant | FR | Servier | INSTITUT DE RECHERCHES SERVIER (PRC) |
participant | DE | Merck | MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN (PRC) |
participant | BE | KUL | KATHOLIEKE UNIVERSITEIT LEUVEN (HES) |